Medical and safety technology provider Dräger has committed an undisclosed sum to the third fund raised by Germany-based public-private investment partnership High-Tech Gründerfonds (HTGF), which has a target size of €310m ($386m). HTGF III began investing in September 2017 after closing an initial $275m in March, and will provide up to €3m in equity funding… Continue reading Dräger drops into HTGF’s third fund
Month: January 2018
Sun Basket bags series D funding
The healthy meal delivery service raised $42.8m from investors including Unilever Ventures along with $15m of debt financing.
Menlo Therapeutics meets public markets with $137m
The pruritus treatment developer, which counts Novo and Merck & Co as shareholders, has closed its initial public offering, its shares having almost doubled in price.
Ripple reaches series C to raise $65m
Ripple Foods, a developer of vegan substitutes for dairy products, increased its overall funding to $110m with a round featuring existing investor GV.
Armo protects bottom line with $128m IPO
The immuno-oncology drug developer, which is backed by Celgene and GV, floated above its range and has since seen its share price rise 75%.
Playtika to put up to $400m into corporate venturing
The social game developer will invest in growth-stage digital entertainment and consumer internet companies through its Playtika Growth Investments fund.
Heetch fetches $20m
Corporate venturing units InnovAllianz and Via ID both invested in the France-based ride hailing service as it prepares to expand geographically.
Appetize cashes up $20m in series B
The R/GA-backed payment processing and inventory management software has now raised $20m in each of its last two funding rounds.
Ikea helps spoon funding to Matsmart
The surplus food e-commerce platform has secured $12.6m in an Ikea-backed round that likely also featured Axel Johnson.
XtalPi extracts $15m in series B round
The pharmaceutical development technology provider has received funding from investors including Google and series A backer Tencent.
Bioceres prepares to plant itself in public markets
The seed and fertliliser producer, which counts Monsanto as an investor, has set the range for an initial public offering that could net up to $142m.
Nexar navigates its way to $30m
The safe-driving app developer took its overall funding to almost $45m with a round featuring Alibaba Innovation Ventures and Nationwide.
Tencent takes a step into Skydance
The China-based corporate has paid more than $100m for a 5% to 10% stake in the film and television producer as part of a partnership agreement.
Solid Biosciences hardens profile with flotation
The Biogen-backed Duchenne muscular dystrophy drug developer saw its share price rise sharply after securing approximately $125m in its IPO.